CHL1 and hepatocellular carcinoma: In addition, we investigated whether the ratios of hsa-miR-182 to its target RNAs (THBS1 and CHL1) and the ratio of hsa-miR-183 to its target RNA (CCNB1) have an impact on the prognosis of patients with HCC.